ABSTRACT Kingella kingae is an emerging bacterial pathogen that is being recognized increasingly as an important etiology of septic arthritis, osteomyelitis, and bacteremia, especially in young children. Colonization of the posterior pharynx is a key step in the pathogenesis of K. kingae disease. Previous work established that type IV pili are necessary for K. kingae adherence to the respiratory epithelium. In this study, we set out to identify additional factors that influence K. kingae interactions with human epithelial cells. We found that genetic disruption of the gene encoding a predicted trimeric autotransporter protein called Knh (Kingella NhhA homolog) resulted in reduced adherence to human epithelial cells. In addition, we established that K. kingae elaborates a surface-associated polysaccharide capsule that requires a predicted ABC-type transporter export operon called ctrA-BCD for surface presentation. Furthermore, we discovered that the presence of a surface capsule interferes with Knh-mediated adherence to human epithelial cells by nonpiliated organisms and that maximal adherence in the presence of a capsule requires the predicted type IV pilus retraction machinery, PilT/PilU. On the basis of the data presented here, we propose a novel adherence mechanism that allows K. kingae to adhere efficiently to human epithelial cells while remaining encapsulated and more resistant to immune clearance.
While it is clear that type IV pili are important for adherence to human epithelial cells, the fact that a significant percentage of pharyngeal isolates are nonpiliated suggests that K. kingae expresses additional surface factors that modulate interactions with host cells. Accordingly, to gain a more thorough understanding of the bacterial factors that potentially influence colonization of the pharynx, we set out to identify additional determinants of adherence to human epithelial cells. This search revealed a novel trimeric autotransporter called Knh (Kingella NhhA homolog), which is necessary for full-level K. kingae adherence to human epithelial cells. Additional studies demonstrated that K. kingae elaborates a surface-associated polysaccharide capsule that interferes with Knh-mediated adherence. Analysis of a K. kingae mutant incapable of pilus retraction suggested that capsule-mediated interference is overcome by the retraction of type IV pili, presumably displacing polysaccharide and facilitating access of Knh to the host cell surface. This adherence mechanism allows K. kingae to adhere efficiently to host cells while remaining encapsulated and resistant to host immune clearance strategies.
RESULTS
K. kingae encodes a novel trimeric autotransporter. K. kingae type IV pili are essential for adherence to human epithelial cells (13) . To identify other factors that might contribute to K. kingae adherence, we examined the draft genome sequence of strain 269-492 for putative adhesive factors by searching for homologs of genes encoding adhesins in other Neisseriaceae family members, including the Neisseria meningitidis Opa, Opc, NadA, and NhhA proteins. This analysis revealed a 5,352-bp open reading frame (ORF) encoding a protein that has C-terminal sequence homology to the N. meningitidis NhhA trimeric autotransporter (accession no. AAK09243.1) and was named Knh (16, 17) . Trimeric autotransporters are a family of adhesive outer membrane proteins classified largely on the basis of the amino acid sequence in the conserved C-terminal beta-barrel membrane anchor domain. Sequence alignment revealed strong membrane anchor domain homology between Knh and NhhA, as well as the Haemophilus influenzae Hia protein (accession no. AAC43721.2) (Fig. 1A) . Additional analysis with SignalP 3.0 (http://www.cbs.dtu.dk/services /SignalP/) revealed a predicted N-terminal signal peptide corresponding to amino acids 1 to 54 and a predicted signal peptidase cleavage site between amino acids 54 and 55, consistent with the possibility that Knh is secreted and surface localized. Domain annotation of Knh was accomplished with the Domain Annotation of Trimeric Autotransporters program (http://toolkit.tuebingen .mpg.de/dataa) and demonstrated an ISneck2 domain with architecture similar to that of the ISneck1 domain that has been associated with adhesive activity in the H. influenzae Hia and Hsf proteins (18) , a series of 19 YadA-like head domains predicted to form a beta-roll on the basis of the Yersinia enterocolitica YadA head domain crystal structure (19, 20) , and a series of eight Trp ring domains spaced between the YadA-like head domain region and the membrane anchor (Fig. 1B) .
To confirm that Knh is a trimeric autotransporter, the ability of the C-terminal beta-barrel domain to trimerize in the outer membrane was examined. A 264-nucleotide fragment of knh encoding amino acids 1695 to 1783, corresponding to the predicted betabarrel membrane anchor, was cloned in frame into pASK-IBA12 (IBA BioTAGnology), which contains an N-terminal Escherichia coli OmpA signal sequence fused to a Strep-tag. The resulting construct, designated pASK::Knh 1695-1783 , was transformed into E. coli BL21 omp8 for induction. After secretion through the inner membrane and cleavage of the OmpA signal sequence, the recombinant Strep-tagged Knh 1695-1783 protein has a predicted monomeric molecular mass of 12 kDa. As is shown in Fig. 1C , induction of pASK::Knh 1695-1783 resulted in the outer membrane localization of a 36-kDa band detected with an anti-Strep monoclonal antibody. As has previously been reported with trimeric autotransporter proteins (21), the trimer was extremely stable under standard boiling and SDS-PAGE denaturing conditions and required an additional formic acid denaturation step to dissociate into monomers (Fig. 1C) . These findings establish that the Knh beta-barrel is sufficient for trimerization in the outer membrane and confirm that Knh is a member of the growing class of trimeric autotransporter proteins.
Knh is expressed in the K. kingae outer membrane and is required for full-level adherence to human epithelial cells. To determine if Knh is expressed and present in the outer membrane of K. kingae strain KK03, sarkosyl-insoluble membrane fractions were isolated and examined by Western blotting with anti-Knh serum. Strain KK03 is a naturally occurring derivative of our prototype K. kingae strain, 269-492, which expresses stable levels of type IV pili and was used as the wild-type (WT) strain throughout this study. As a negative control, a Knh mutant was created by insertionally inactivating knh in strain KK03. Under standard SDS-PAGE denaturing conditions, a high-molecular-mass band was evident in outer membrane preparations of strain KK03 and the nonpiliated, nonadherent pilA1 mutant but not in those of the knh mutant ( Fig. 2A) . While the high molecular mass of this reactive band precludes accurate size estimation, it is consistent with the trimer form of Knh, which has a predicted molecular mass of 540 kDa. Formic acid treatment of outer membranes resulted in elimination of the high-molecular-mass band and detection of a band corresponding to the predicted monomeric molecular mass (180 kDa) of Knh in strains KK03 and KK03pilA1 but not in strain KK03knh (Fig. 2B) . To complement the knh mutation, the knh ORF with the native promoter region was recombined into a separate locus in the genome in the KK03knh strain background (see Fig. S1 in the supplemental material for the complementation strategy used). (To date, plasmids that replicate in K. kingae are unavailable.) As shown in Fig. 2A and B, outer membrane localization of Knh was restored in complemented strain KK03knh/ (knh). Semiquantitative extracellular pilus preparation analysis using strain KK03pilA1 as a negative control revealed no difference in piliation levels among strains KK03, KK03knh, and KK03knh/(knh) (data not shown).
To K. kingae produces a surface-associated polysaccharide capsule. The observation that type IV pili are required for Knh-mediated adherence suggested that K. kingae may express another surface factor that blocks Knh adhesive activity. Examination of K. kingae strain KK03 revealed a mucoid colony phenotype similar to that seen with other bacterial species that produce a polysaccharide capsule (Fig. 3A) . To explore the possibility that K. kingae expresses a polysaccharide capsule, the draft genome sequence was searched for homologs to genes involved in capsule synthesis and export in N. meningitidis, a wellstudied Neisseriaceae family member that contains the siaABCD, ctrABCD, ctrE/lipA, and ctrF/lipB capsule-associated genes. As summarized in Table S1 in the supplemental material, an intact locus with homology to the ABC-type capsule export operon ctrA-BCD of N. meningitidis and unlinked genes with homology to the ctrE/lipA and ctrF/lipB genes were identified in the K. kingae genome. To determine if the ctrABCD operon plays a role in K. kingae encapsulation, ctrA was insertionally inactivated. As shown in Fig. 3B , examination of KK03ctrA revealed nonmucoid colonies, in marked contrast to the colonies of parental strain KK03. To confirm that K. kingae elaborates a polysaccharide capsule, strains KK03 and KK03ctrA were stained with cationic ferritin and then examined by thin-section transmission electron microscopy (TEM). Because of the highly anionic nature of most bacterial polysaccharide capsules, cationic ferritin typically binds to the capsular material, producing an electron-dense rim on the bacterial surface when visualized by thin-section TEM. A thick layer of electron density was evident on the surface of WT strain KK03 ( Fig. 3C ) and was absent from mutant strain KK03ctrA (Fig. 3D ). Attempts to complement the mutation in ctrA and the likely polar effect on the ctrBCD genes were unsuccessful. Sequencing of our chromosomal complementation construct containing ctrABCD generated in E. coli consistently revealed nonsense or frameshift mutations in ctrA, presumably reflecting the inability of E. coli to tolerate the expression of the outer membrane protein encoded by ctrA. However, quantitative reverse transcription (qRT)-PCR analysis revealed that transcription of the ORF downstream of the ctrABCD operon was unaffected by the ctrA insertion mutation (see Fig. S2 in the supplemental material), supporting the conclusion that the phenotypes observed as a result of the ctrA mutation are due to disruption of the ctrABCD operon.
As a complementary approach to demonstrate the presence of a capsule, surface material was released from bacterial suspensions by heat extraction at 55°C, resolved by SDS-PAGE, and then stained with alcian blue (22) . As shown in Fig. 3E , highmolecular-mass, alcian blue-reactive material was present in strain KK03 but absent from strain KK03ctrA. H. influenzae strain C54, which expresses a type b polysaccharide capsule, and H. influenzae strain C54b-, an isogenic mutant that is nonencapsulated, were used as controls. The alcian blue-reactive material did not stain with Coomassie blue and was unaffected by proteinase K treatment (data not shown), confirming that the extracted material is not proteinaceous.
Together, these data indicate that K. kingae strain KK03 expresses a surface-associated polysaccharide capsule that requires the predicted ctrABCD capsule export operon for surface localization.
Type IV pili, capsule, and Knh influence K. kingae adherence to human epithelial cells. To further explore the interrelationship between type IV pili, Knh, and the capsule in terms of their effects on bacterial adherence, we generated single, double, and triple mutations in pilA1, knh, and ctrA. Extracellular pilus preparations revealed no change in pilus expression levels in mutant strains with an intact pilA1 gene (data not shown). As shown in Fig. 4 , insertional inactivation of ctrA in strain KK03 resulted in a slight decrease in adherence that was not statistically significant. The adherence of the KK03ctrA/knh double mutant mimicked the levels seen in the knh single mutant, indicating that encapsulation does not influence type IV pilus-mediated adherence in the absence of Knh. Interestingly, while the pilA1 mutant was nonadherent, simultaneous disruption of pilA1 and ctrA in the KK03 background restored high-level adherence (P Ͻ 0.05 for the pilA1/ctrA mutant versus the pilA1 mutant), indicating that encapsulation inhibits pilus-independent Knh-mediated adherence. The pilA1/ ctrA/knh triple mutant was nonadherent, providing strong evidence that Knh is an adhesin and is responsible for the K. kingae pilusindependent adherence observed in the pilA1/ ctrA double mutant (P Ͻ 0.05 for the pilA1/ctrA/ knh mutant versus the pilA1/ctrA mutant).
The type IV pilus retraction ATPase system is required for full-level adherence. The observation that the capsule interferes with Knhmediated adherence in the absence of pili but not in the presence of pili raised the possibility that pilus-mediated adherence draws the organism closer to the host cell surface, perhaps via pilus retraction. In accordance with this possibility, K. kingae encodes a homolog of the PilT/ PilU retraction ATPase machinery that has been shown to be essential for pilus retraction in several well-studied type IV pilus-expressing bacteria, including N. meningitidis, N. gonorrhoeae, Pseudomonas aeruginosa, and Myxococcus xanthus (23) (24) (25) (26) . To determine if pilus retraction is necessary for full-level K. kingae adherence, pilT was insertionally inactivated in strain KK03. As the insertion in pilT likely had a polar effect on pilU, the pilTU operon with the native promoter was recombined into the chromosome to achieve complementation. Examination of KK03pilT revealed increased levels of extracellular pili, as assessed by semiquantitative pilus preparations (Fig. 5A ), but lacked twitching motility, as assessed by a modification of the P. aeruginosa agar stab assay (Fig. 5B) (27) , consistent with the hypothesis that the PilT/PilU retraction ATPase machinery is necessary for K. kingae pilus retraction. As shown in Fig. 5C , elimination of PilT/PilU resulted in adherence that was decreased compared to that of parent strain KK03 (P Ͻ 0.05) but equal to that of the knh mutant. Complementation of the pilTU operon in the pilT mutant background resulted in reduction of extracellular pilus expression to the WT level and restoration of twitching motility and adherence (Fig. 5A to C) . The observation that the knh and pilT mutants have similar adherence levels suggests that both retractable and nonretractable pili mediate a basal level of adherence and that the pilT mutant is unable to utilize Knh as an adhesin. We next investigated if full-level adherence could be restored in the pilT mutant by surface capsule elimination via disruption of ctrA. As expected, the ctrA/pilT double mutant adhered to epithelial cells at the WT level (Fig. 5C ). These data support the hypothesis that retraction of type IV pili is necessary to overcome the inhibitory influence of the capsule on Knh-mediated adherence.
DISCUSSION
The pathogenesis of K. kingae disease is thought to begin with colonization of the upper respiratory tract. Previous work established that type IV pili promote K. kingae adherence to human epithelial cells (13) . In this study, we identified a novel K. kingae trimeric autotransporter protein called Knh that also mediates adherence to human epithelial cells. Further analysis revealed that K. kingae expresses a polysaccharide capsule that interferes with Knh adhesive activity when type IV pili are absent. We observed that type IV pili are important to overcome the polysaccharide capsule and facilitate Knh-mediated adherence in the presence of the PilT/PilU ATPase retraction machinery, presumably as a result of pilus retraction.
Trimeric autotransporters are integral outer membrane proteins and appear to be universally associated with adhesive activity (28) . In our study, K. kingae derivatives expressing the trimeric autotransporter Knh but lacking type IV pili and a capsule were adherent, while those lacking Knh, type IV pili, and a capsule were nonadherent, providing strong evidence that Knh is an adhesin. Analysis of the Knh amino acid sequence revealed the presence of conserved domains possibly involved in adhesive activity. The N-terminal region of Knh is predicted to encode three clusters of ␤-roll degenerate repeats termed YadA-like head domains based on characterization of the Y. enterocolitica YadA trimeric autotransporter adhesin. Studies of YadA have demonstrated that the head domain is responsible for YadA-mediated adhesive activity (20, 29) , raising the possibility that this domain is involved in Knh adhesive function as well. In addition, Knh has an ISneck2 domain that is similar to the ISneck1 domain identified in the adhesive regions of the H. influenzae Hia and Hsf adhesins (18) . It is interesting to speculate regarding the location of the adhesive domain(s) of Knh relative to the outer membrane and the presence of a capsule. We have clearly demonstrated that a nonpiliated K. kingae mutant that expresses Knh and a capsule is nonadherent. One possible explanation for this phenotype is that the adhesive domain of Knh is buried within the capsule and is thus not accessible to the host cell receptor. The ISneck2 domain is proximal to the membrane anchor, suggesting that it is likely to be located close to the bacterial surface and may be masked by surface structures, including the polysaccharide capsule. The YadA-like head domains are located distally and are also presumably masked by the polysaccharide capsule, perhaps unless the capsule is displaced.
Encapsulation of bacterial pathogens has been shown to confer phenotypes important for survival on the host, including antiphagocytic activity and serum resistance. In this study, we report that K. kingae expresses a surface-associated polysaccharide capsule. According to current understanding, the pathogenesis of K. kingae disease begins with colonization of the upper respiratory tract, followed by hematogenous dissemination to joints, bones, or the endocardium (8) . This pathogenic sequence is supported by the finding that genotypically identical K. kingae strains can be isolated from the pharynx and bloodstream of patients with sys-
FIG 5
PilT/PilU retraction ATPase machinery influences K. kingae piliation, twitching motility, and adherence. K. kingae strains KK03, KK03pilA1, KK03knh, KK03pilT, KK03pilT/(pilTU), and KK03ctrA/pilT were examined for extracellular pilus expression by semiquantitative pilus preparation (A), twitching motility by a modified agar stab assay (scale bar, 1 cm) (B), and adherence to Chang human epithelial cells (C). Adherence assays were conducted in triplicate. Error bars indicate standard errors of the means. Statistical analyses were performed by using the unpaired t test to compare the adherence levels of two strains as follows: P Ͻ 0.05 (*) for KK03 versus KK03pilT and for KK03pilT versus KK03pilT/(pilTU). temic disease (12) . We speculate that encapsulation is important for K. kingae to cause invasive disease by promoting intravascular survival, similar to observations with N. meningitidis, H. influenzae, and other encapsulated pathogens (30) (31) (32) (33) (34) . Studies are under way to investigate the role of the K. kingae capsule in serum resistance and antiphagocytic activity. In addition to expressing a surface-associated polysaccharide capsule, K. kingae produces a secreted exopolysaccharide galactan that has broad antibiofilm activity (35) . At this time, the relationship between the capsular polysaccharide and the galactan is unclear.
This study established that surface expression of the K. kingae capsule requires a predicted ABC-type transporter system with homology to CtrABCD in N. meningitidis. We also identified homologs of the N. meningitidis CtrE/LipA and CtrF/LipB proteins (36, 37) . Both of these proteins also have homologs in the E. coli group 2 and 3 capsule biosynthesis systems (KpsC and KpsS) and in encapsulated H. influenzae (HcsA and HcsB) and appear to play a role in the export of capsule polymers to the bacterial surface (38, 39) . Interestingly, the genetic organization of the polysaccharide synthesis machinery in K. kingae differs from that of E. coli groups 2 and 3, H. influenzae, and N. meningitidis. In N. meningitidis, a capsule synthesis operon (which differs in gene composition, depending on the specific capsule serotype) is located immediately upstream of the ctrABCD export operon and is divergently transcribed (40, 41) . In E. coli group 2, the synthesis operon is located immediately between the export and assembly operons, and in H. influenzae, the synthesis operon is adjacent to the export operon (42) (43) (44) (45) (46) . We have been unable to locate a putative capsule synthesis operon adjacent to ctrABCD or at any other locus in our draft K. kingae genome sequence, suggesting that K. kingae utilizes a unique genetic mechanism for the synthesis of capsular polysaccharide in a system that utilizes the ABC-type transporter system for export.
We first suspected that the capsule may be obstructing the ability of Knh to mediate adherence when we found that a mutant KK03 strain expressing a capsule and Knh but lacking pili was nonadherent. In considering this possibility, elaboration of a polysaccharide capsule has been shown to interfere with adhesive interactions with the host in several other pathogens. For example, the capsule interferes with adherence to human epithelial cells by H. influenzae type b (47), with adherence to gastrointestinal epithelium by enterotoxigenic E. coli (48) , and with N. meningitidis Opa-and Opc-mediated adherence to epithelial and endothelial cells (49, 50) . It is intriguing that the adherence of the ctrA mutant is slightly decreased compared that of parental strain KK03. While it is clear that the surface capsule blocks Knh-mediated adherence in the absence of type IV pili, we speculate that interaction of pili, Knh, and the capsule is necessary for full-level adherence of the WT organism. It is interesting to compare the K. kingae adherence data presented here with the adherence mechanism of N. meningitidis, a related encapsulated member of the Neisseriaceae family. N. meningitidis uses a two-step adherence process that starts with an initial type IV pilus-mediated interaction associated with microcolony formation on the host cell (51) . Type IV pili are the key surface factor for adherence of encapsulated N. meningitidis to the epithelium and endothelium (52, 53) . Following the initial adhesive interaction, type IV pili and the capsule are downregulated during the transition to the second stage of host cell interaction, which is termed intimate adherence (51, 54, 55) . The shift from initial adherence to intimate adherence occurs over a course of hours, leading to host cell cytoskeletal rearrangements and cortical plaque formation under the intimately adherent bacteria (51, 56) . Interestingly, we were able to detect high-level adherence after an only 25-min incubation of WT K. kingae with human epithelial cells, indicating that type IV pili are able to rapidly overcome the inhibitory influence of the capsule on Knh-mediated adherence, apparently via PilT/PilU-mediated retraction. We have observed similar adherence after a 5-min incubation (data not shown), which argues against the downregulation of capsule expression. These results suggest that K. kingae has developed a unique mechanism to efficiently adhere to host cells without having to downregulate capsule expression and become more susceptible to immune clearance.
We propose a model for K. kingae adherence to human epithelial cells focusing on the three surface factors examined in this study: type IV pili, Knh, and the capsule (Fig. 6) . This model involves a two-step process that begins with a low-affinity adhesive event mediated by type IV pili, as these fibers are able to extend beyond the polysaccharide capsule and engage their host cell receptor. PilT/PilU-mediated pilus retraction then brings the bacterium into close contact with the host cell, causing physical displacement of the surface polysaccharide capsule. Once the capsule has been displaced, Knh is able to engage its host cell receptor, leading to the high-level adherence we observe in adherence assays. It is important to note that this model relies on strong pilus retraction forces to displace the capsule. The force generated by a single Myxococcus xanthus type IV pilus has been measured at 150 pN, making this the strongest linear molecular motor described to date (57) . Similar measurements have been made for N. gonorrhoeae type IV pili, suggesting that the strong forces generated by these bacterial organelles may be conserved in the Neisseriaceae family (58) .
Our results establish a potential mechanism by which K. kingae adheres to the host respiratory epithelium and promotes colonization of the upper respiratory tract. However, the precise interrelationship and regulatory mechanisms of the three surface factors presented here have yet to be determined. Further investigation of the K. kingae adherence mechanism may lead to novel strategies for the prevention of disease due to K. kingae and to other encapsulated pathogenic bacteria.
MATERIALS AND METHODS
Bacterial strains. The strains used in this study are listed in Table S2 in the supplemental material. Strain 269-492 forms two distinct colony morphologies on solid agar that are referred to as KK01 and KK03. KK01 is associated with stable low-level piliation, and KK03 is associated with stable high-level piliation. KK03 was used as the WT strain throughout this study to control for the piliation level. K. kingae strains were stored at Ϫ80°C in brain heart infusion broth with 30% glycerol. E. coli strains were stored at Ϫ80°C in Luria-Bertani (LB) broth with 15% glycerol. K. kingae strains were routinely cultured at 37°C with 5% CO 2 on chocolate agar supplemented with 50 g/ml kanamycin, 1 g/ml erythromycin, or 2 g/ml tetracycline, as appropriate. E. coli strains were routinely cultured at 37°C in LB broth or on LB agar supplemented with 100 g/ml ampicillin, 50 g/ml kanamycin, 500 g/ml erythromycin, or 12.5 g/ml tetracycline, as appropriate.
Genetic disruptions. Gene disruptions were introduced into K. kingae by natural transformation (59) . Following recovery of transformants by plating on selective medium, correct localization of the gene disruptions was confirmed by Southern blotting or PCR. The pilA1 gene was disrupted as described previously (13) . All of the plasmids used in this study are listed in Table S2 in the supplemental material, and the sequences of all of the primers used are listed in Table S3 . To disrupt the knh gene, fragments corresponding to the 5= and 3= regions of the gene were individually amplified from K. kingae strain 269-492 by using primers knh5= F and knh5= R and primers knh3= F and knh3= R, respectively. These fragments were ligated into BamHI/SalI-digested pTrc99A (introducing an internal deletion and a ClaI site within knh), generating pTrc99A/knh::ClaI. The tetM tetracycline resistance cassette was amplified with flanking ClaI sites from pHSXtetM4 using primers tetM F and tetM R and ligated into pTrc99A/ knh::ClaI, generating pTrc99A/knh::tetM. To disrupt the ctrA gene, a fragment containing most of the ctrA ORF and the upstream flanking sequence was amplified from K. kingae strain 269-492 with primers ctrA F and ctrA R and ligated into BamHI/HindIII-digested pUC19, generating pUC19/ctrA. Subsequently, the QuikChange XL site-directed mutagenesis kit (Agilent Technologies) was used to insert an MluI site into the ctrA ORF by using primers ctrA MluI F and ctrA MluI R, generating pUC19/ ctrA::MluI. The erythromycin resistance cassette ermC was amplified with flanking MluI sites from pIDN4 by using primers ermC F and ermC R and ligated into pUC19/ctrA::MluI, generating pUC19/ctrA::ermC. To disrupt the pilT gene, a fragment containing most of the pilT ORF and the upstream flanking sequence was amplified from K. kingae strain 269-492 with primers pilT F and pilT R and ligated into BamHI/HindIII-digested pUC19, generating pUC19/pilT. Subsequently, site-direct mutagenesis was used to insert an MluI site into the pilT ORF by using primers pilT MluI F and pilT MluI R, generating pUC19/pilT::MluI. The kanamycin resistance cassette aphA3 was excised from pFalcon2 by digestion with MluI and ligated into MluI-digested pUC19/pilT::MluI, generating pUC19/pilT::aphA3. To rule out PilA1 amino acid sequence variation as a source of phenotypic changes, the pilA1 gene in all strains that did not contain the pilA1 disruption was sequenced and confirmed to be 100% identical to the KK03 pilA1 sequence. To exclude possible phase-variable events in the mutants generated in this study, all strains were examined for pilus production by using extracellular pilus preparations, Knh production using Western blotting, and capsule production using heat extraction and alcian blue staining to confirm the presence or absence of the three surface factors under study.
The genetic complementation strategy used is detailed in Fig. S1 and Text S1 in the supplemental material.
Cationic ferritin staining. Derivatives of K. kingae strain KK03 were incubated on chocolate agar for 17 to 18 h, and growth was suspended in 3 ml 0.1 M sodium cacodylate, pH 7.0 (cacodylate buffer), to an OD 600 of 0.8. Glutaraldehyde was added to a final concentration of 5%, and samples were incubated for 20 min at ambient temperature. Following centrifugation at 750 ϫ g for 15 min, pellets were gently resuspended in 1 ml cacodylate buffer, polycationic ferritin (Sigma) was added to a final concentration of 1 mg/ml, and samples were incubated for 30 min at ambient temperature and then centrifuged at 750 ϫ g for 15 min. The pellets were washed once with 1 ml cacodylate buffer, resuspended in cacodylate buffer with 5% glutaraldehyde, incubated for 2 h at ambient temperature and then overnight at 4°C, and processed for TEM analysis.
TEM. To assess surface capsule expression, cationic-ferritin-stained bacteria were washed three times with cacodylate buffer, embedded in 2% low-melting-point agarose, and fixed in cacodylate buffer with 4% glutaraldehyde and 7.5% sucrose. The pellets were postfixed in 1% osmium tetroxide in cacodylate buffer, stained en bloc with 0.5% uranyl acetate, dehydrated with a graded series of ethanol, and embedded in epoxy resin. Blocks were cut into thin sections (60 to 90 nm), placed on copperrhodium 200-mesh grids, and examined by using a Philips CM-12 electron microscope.
Twitching motility assays. Twitching motility was assessed by a modified agar plate stab assay originally developed for P. aeruginosa (27) . Briefly, derivatives of K. kingae strain KK03 were incubated on chocolate agar for 17 to 18 h and growth was resuspended in 1ϫ PBS to an OD 600 of 1.0. One microliter of the bacterial suspension was stab inoculated into the bottom of tissue culture-treated 100-mm plates containing chocolate agar and incubated at 37°C with 5% CO 2 for 2 days. Twitching motilitycompetent strains spread from the stab inoculation site at the plate-agar interface. The agar was carefully peeled away, and the plate was air dried and stained with crystal violet to visualize the twitching motility zones.
Eukaryotic cell lines and adherence. Chang cells (Wong-Kilbourne derivative [D] of Chang conjunctiva, HeLa origin; ATCC CCL-20.2) were cultivated at 37°C with 5% CO 2 in medium as described previously (13) . Quantitative adherence assays were performed as described previously (13) . Briefly, confluent and fixed cell monolayers in 24-well plates were inoculated with approximately 6.5 ϫ 10 6 CFU of bacteria and the plates were centrifuged at 165 ϫ g for 5 min and then incubated for 25 min at 37°C in 5% CO 2 . Monolayers were washed four times with PBS to remove nonadherent bacteria and then treated with 1ϫ trypsin-EDTA (Sigma) for 20 min at 37°C to release adherent bacteria. Percent adherence was calculated by dividing the number of adherent CFU by the number of inoculated CFU. All experiments were performed in triplicate. Statistical analysis was performed using the unpaired t test to compare the adherence levels of two strains as noted in the figure legends.
Nucleotide sequence accession numbers. The nucleotide sequences of the ctrABCD, ctrE, ctrF, and knh loci have been submitted to GenBank and assigned accession numbers JX944815 (ctrABCD), JX944816 (ctrE), JX944817 (ctrF), and JX944818 (knh).
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